International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e602-e607 , July 2010

Human immunodeficiency virus–hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand

  • Nicole Ngo-Giang-Huong

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • Harvard School of Public Health, Boston, Massachusetts, USA
    • Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    • Corresponding Author InformationCorresponding author. Tel.: +66 53 894 431; fax: +66 53 894 220.
    • ,
  • Gonzague Jourdain

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • Harvard School of Public Health, Boston, Massachusetts, USA
    • Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    • ,
  • Wasna Sirirungsi

      Affiliations

    • Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    • ,
  • Luc Decker

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • ,
  • Woottichai Khamduang

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • ,
  • Sophie Le Cœur

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • Institut National d’Etudes Demographiques, Université Paris Descartes, Paris, France
    • ,
  • Surat Sirinontakan

      Affiliations

    • Health Promotion Hospital Regional Center I, Bangkok, Thailand
    • ,
  • Rosalin Somsamai

      Affiliations

    • Lamphun Hospital, Lamphun, Thailand
    • ,
  • Karin Pagdi

      Affiliations

    • Lamphun Hospital, Lamphun, Thailand
    • ,
  • Jittapol Hemvuttiphan

      Affiliations

    • Phayao Hospital, Phayao, Thailand
    • ,
  • Kenneth McIntosh

      Affiliations

    • Department of Pediatrics, Harvard Medical School, Children's Hospital Boston, Boston, USA
    • ,
  • Francis Barin

      Affiliations

    • Laboratoire de Virologie and Centre National de Référence pour le VIH, Université F. Rabelais, Tours, France
    • ,
  • Marc Lallemant

      Affiliations

    • Institut de Recherche pour le Développement (IRD), U174 – Program for HIV Prevention and Treatment (PHPT), Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    • Harvard School of Public Health, Boston, Massachusetts, USA
    • Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand

Received 1 May 2009 ,Revised 31 August 2009 ,Accepted 7 September 2009.

References 

  1. Global Burden Of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44:20–9.
  2. Perz JF, Farrington LA, Pecorado C, Hutin YJ, Armstrong GL. Estimated global prevalence of hepatitis C virus infection. In: 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, USA, September 30–October 3. 2004;
  3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–567
  4. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887–891
  5. Feldman JG, Minkoff H, Landesman S, Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis. 2000;27:338–342
  6. Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B, Williams I, et al. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997–2000. Sex Transm Dis. 2003;30:919–924
  7. Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Infect Dis. 2001;184:359–363
  8. Stroffolini T, Lorenzoni U, Menniti-Ippolito F, Infantolino D, Chiaramonte M. Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors?. Am J Gastroenterol. 2001;96:3138–3141
  9. Wyld R, Robertson JR, Brettle RP, Mellor J, Prescott L, Simmonds P. Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals. J Infect. 1997;35:163–166
  10. Eicher AD, Crofts N, Benjamin S, Deutschmann P, Rodger AJ. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care. 2000;12:497–504
  11. Hansurabhanon T, Jiraphongsa C, Tunsakun P, Sukbunsung R, Bunyamanee B, Kuirat P, et al. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand. Ann Trop Med Parasitol. 2002;96:615–625
  12. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006;74:1111–1116
  13. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92:385–387
  14. Zhang C, Yang R, Xia X, Qin S, Dai J, Zhang Z, et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan. China. J Acquir Immune Defic Syndr. 2002;29:191–196
  15. Dal Molin G, D’Agaro P, Ansaldi F, Ciana G, Fertz C, Alberico S, et al. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol. 2002;67:137–142
  16. Ferrero S, Lungaro P, Bruzzone BM, Gotta C, Bentivoglio G, Ragni N. Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990–2000). Acta Obstet Gynecol Scand. 2003;82:229–234
  17. Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis. 2007;44:1123–1131
  18. Thomas DL, Villano SA, Riester KA, Hershow R, Mofenson LM, Landesman SH, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis. 1998;177:1480–1488
  19. Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol. 1998;27:108–117
  20. Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics. 1998;102:355–359
  21. Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, et al. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr. 2001;33:570–575
  22. Moriya T, Sasaki F, Mizui M, Ohno N, Mohri H, Mishiro S, et al. Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomed Pharmacother. 1995;49:59–64
  23. Ruiz-Extremera A, Salmeron J, Torres C, De Rueda PM, Gimenez F, Robles C, et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission. Pediatr Infect Dis J. 2000;19:511–516
  24. Spencer JD, Latt N, Beeby PJ, Collins E, Saunders JB, McCaughan GW, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat. 1997;4:395–409
  25. Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis. 2003;187:345–351
  26. Xiong SK, Okajima Y, Ishikawa K, Watanabe H, Inaba N. Vertical transmission of hepatitis C virus: risk factors and infantile prognosis. J Obstet Gynaecol Res. 1998;24:57–61
  27. Chang MH. Mother-to-infant transmission of hepatitis C virus. Clin Invest Med. 1996;19:368–372
  28. Hershow RC, Riester KA, Lew J, Quinn TC, Mofenson LM, Davenny K, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study. J Infect Dis. 1997;176:414–420
  29. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192:1880–1889
  30. Papaevangelou V, Pollack H, Rochford G, Kokka R, Hou Z, Chernoff D, et al. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis. 1998;178:1047–1052
  31. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol. 2003;32:727–734
  32. Syriopoulou V, Nikolopoulou G, Daikos GL, Theodoridou M, Pavlopoulou I, Nicolaidou P, et al. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis. 2005;37:350–353
  33. European Paediatric Hepatitis C Virus Network. A significant sex – but not elective cesarean section – effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005; 192:1872–9.
  34. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356:904–907
  35. Marine-Barjoan E, Berrebi A, Giordanengo V, Favre SF, Haas H, Moreigne M, et al. HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?. AIDS. 2007;21:1811–1815
  36. Ministry of Public Health of the Kingdom of Thailand. HIV sero-surveillance in Thailand: result of the 23rd round, June 2005. Nonthaburi: Ministry of Public Health of the Kingdom of Thailand; 2005.
  37. Jamieson DJ, Skunodom N, Chaowanachan T, Roongpisuthipong A, Bower WA, Chotpitayasunondh T, et al. Infection with hepatitis C virus among HIV-infected pregnant women in Thailand. Infect Dis Obstet Gynecol. 2008;2008:840948
  38. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000;343:982–991
  39. Lemaire JM, Courouce AM, Defer C, Bouchardeau F, Coste J, Agulles O, et al. HCV RNA in blood donors with isolated reactivities by third-generation RIBA. Transfusion. 2000;40:867–870
  40. Dunn DT, Gibb DM, Healy M, Goodall RL, Butler K, Cafferkey M, et al. Timing and interpretation of tests for diagnosing perinatally acquired hepatitis C virus infection. Pediatr Infect Dis J. 2001;20:715–716
  41. Nantachit N, Robison V, Wongthanee A, Kamtorn N, Suriyanon V, Nelson KE. Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion. 2003;43:730–735
  42. Luengrojanakul P, Vareesangthip K, Chainuvati T, Murata K, Tsuda F, Tokita H, et al. Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol. 1994;44:287–292
  43. Songsivilai S, Jinathongthai S, Wongsena W, Tiangpitayakorn C, Dharakul T. High prevalence of hepatitis C infection among blood donors in northeastern Thailand. Am J Trop Med Hyg. 1997;57:66–69
  44. Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion. 2004;44:1433–1440
  45. Paris R, Sirisopana N, Benenson M, Amphaiphis R, Tuntichaivanich C, Myint KS, et al. The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand. AIDS. 2003;17:1363–1367
  46. Zanetti AR, Tanzi E, Newell ML. Mother-to-infant transmission of hepatitis C virus. J Hepatol. 1999;31(Suppl 1):96–100

☆ This work was presented in part at the 5th Dominique Dormont International Conference, Paris, France, March 26–28, 2009.

PII: S1201-9712(09)00360-9

doi: 10.1016/j.ijid.2009.09.002

International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e602-e607 , July 2010

Article Tools

* Image Usage & Resolution